Celyad Oncology Alternatives & Competitors

12 companies similar to Celyad Oncology —

NiKang Therapeutics Inc.

37 Series C $260.00M

Wilmington, United States

Biotechnology Health Care

RayzeBio

Targeted innovative radiopharmaceuticals for cancer

258 Acquired $4.78B

San Diego, United States

Biotechnology Health Care +2

Glycyx

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...

3 Series A $7.10M

San Francisco, United Sta...

Biopharma Biotechnology +1

FREZENT Biological

Preventing cancer recurrence

10 Seed

New York, United States

Biotechnology Health Care +1

Track all Celyad Oncology competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

CatalYm GmbH

Developing innovative immunotherapies to transform cancer patients’ lives by engaging thei...

58 Series D $250.00M

Germany

Biotechnology Health Care +1

Avacta Therapeutics

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform.

44 Post Ipo Equity

London, United Kingdom

Biotechnology Health Care +1

Exelixis

Exelixis works on discovering, developing, and commercializing therapies for the treatment...

1566 IPO $340.26M

Alameda, United States

Biotechnology

Crossbow Therapeutics, Inc

Established antibody engineering to target the untapped universe of intracellular cancer t...

45 Series B $157.00M

Cambridge, United States

Biotechnology Health Care +1

Cure51

We want every patient to become a Cancer Survivor.

61 Seed $15.00M

Paris, France

Biotechnology Pharmaceutical

Arcellx

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

224 Acquired $8.43B

Redwood City, United Stat...

Biopharma Biotechnology +3

ImmunoGen

Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, a...

34 Acquired $681.30M

Biotechnology Health Care +1

Prelude Therapeutics

Precision Oncology, Redefined.

126 Post Ipo Equity $147.00M

Wilmington, United States

Biopharma Biotechnology +2

About Celyad Oncology

Services

Development of CAR T-cell candidates, Biotechnology innovation, Therapeutics development

Target Customers

Healthcare providers, Oncologists, Cancer research facilities, Pharmaceutical companies

Taxonomy

Cell Therapy, Intellectual Property, Immuno-Oncology, Cardiology, CAR-T NKR-2, C-Cure, CYAD-01, CYAD-02, CYAD-03, CAR T-cells, Immunotherapy, NKG2D, ShRNA Multiplex

Business Model

B2B, B2D

Revenue Model

Licensing, Product Sales

Frequently Asked Questions

Top alternatives to Celyad Oncology include NiKang Therapeutics Inc., RayzeBio, Glycyx, FREZENT Biological, CatalYm GmbH. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Celyad Oncology based on industry overlap, target customers, and business model.

Don't just read about them. Follow them.

BounceWatch watches Celyad Oncology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Celyad Oncology Profile NiKang Therapeutics Inc. Alternatives RayzeBio Alternatives Glycyx Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Celyad Oncology on 11 Mar 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 25 Aug 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.